Status:
COMPLETED
Covid-19 Breath Test
Lead Sponsor:
Ancon Technologies Ltd
Conditions:
Covid-19 Infection
Eligibility:
All Genders
16+ years
Phase:
NA
Brief Summary
Can Nanotechnology Biomarker Tagging (NBT) be used to detect COVID-19 infection in people presenting for COVID-19 testing? NBT can be used to detect the substances present in a person's breath. In th...
Detailed Description
This is a Cohort Study which will collect non-invasive, expired breath sample, cheek swab and a Medical and Lifestyle questionnaire from participants. When the participant presents for COVID-19 testi...
Eligibility Criteria
Inclusion
- Male \& Females.
- Age Above 16 years old
- All Ethnicity
- Any patients that come for COVID-19 testing
- COVID Negative Patients (Further participants may be selected as control groups who have no current diagnosis of COVID-19.)
- COVID Positive In-Patients
Exclusion
- Outside of stated age range - below 16
- Unable to consent
Key Trial Info
Start Date :
June 29 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 7 2021
Estimated Enrollment :
330 Patients enrolled
Trial Details
Trial ID
NCT04459962
Start Date
June 29 2020
End Date
January 7 2021
Last Update
January 29 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ashford and St Peter's Hospitals NHS Foundation Trust
Chertsey, Surrey, United Kingdom, KT16 0PZ